By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.

Revolutionary On-Demand Cellular Controls and
Cell Lines

Helping you secure your work because your career will inform the future

Schedule a Free Consultation
Reliable / Consistent / Sustainable

Introducing On-Demand Cell/Cell Line Mimics

The Revolutionary Way to Win

Biomarker controls that
provide confidence
Learn More
Tunability that sets
the standard
Learn More
Rapid on-demand
manufacturing that
saves time and money
Learn More

Every scientist knows what it means when we say your “payday” is useful data. You shouldn’t have to work without the appropriate controls.

It is unfair to expect scientists to instinctively know how to analyze complex data without appropriate controls to inform that analysis.

Scientist at computer
  • YOUR samples are too important to risk them resulting in no/unreliable data
  • YOUR disease X is too serious to waste even one more experiment
  • YOUR instrument and reagent investment was robust; maximize the data you generate from it

Make every experiment a payday.

It’s no secret that there are a lot of unknowns and inherent waste in high parameter biology/biomarker discovery. Your work isn’t simple, but it can be simplified. We will help you avoid the waste and eliminate the unknowns.

Are you confident with your data?

Check out our Q&A to see where your project is most vulnerable so you can stop feeling anxious about your data and instead confidently generate meaningful results that can be shared with and repeated by others.

Download Free PDF

Free Download: Case Study

Introducing a Cell Line Mimic to Support Acute Myeloid Leukemia Diagnosis

A prominent global pharmaceutical company was addressing the challenge of an appropriate control for acute myeloid leukemia (AML) by using the Kasumi-3 cell line as diagnostic reference QC material.